☰

Yifan Tu, Ph.D. - Publications

Affiliations: 
2008 Molecular & Cellular Biology University of Massachusetts, Amherst, Amherst, MA 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shi H, Liu J, Tu Y, Freter CE, Huang C. Oolong Tea Extract Induces DNA Damage and Cleavage and Inhibits Breast Cancer Cell Growth and Tumorigenesis. Anticancer Research. 38: 6217-6223. PMID 30396940 DOI: 10.21873/anticanres.12976  0.436
2018 Hinyard LJ, Schoen MW, Chen J, Tu Y, Rodin MB. Diabetes outcomes in patients with a history of breast cancer. Journal of Clinical Oncology. 36: 8-8. DOI: 10.1200/Jco.2018.36.7_Suppl.8  0.375
2018 Schoen MW, Chen J, Tu Y, Mohammed KA, Rodin MB, Hinyard LJ. Diabetes outcomes in patients with breast cancer. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E22078  0.464
2017 Mehta HN, Farhat R, Ravulapati S, Tu Y. Relevance of rapid geriatric assessment for elderly patients with newly diagnosed malignancy. Journal of Clinical Oncology. 35: 115-115. DOI: 10.1200/Jco.2017.35.31_Suppl.115  0.328
2014 Kalinsky K, Lim EA, Andreopoulou E, Desai AM, Jin Z, Tu Y, Hibshoosh H, Wang A, Greenlee H, Crew KD, Maurer M, Sparano JA, Hershman DL. Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer. Cancer Investigation. 32: 439-44. PMID 25254601 DOI: 10.3109/07357907.2014.958232  0.415
2014 Tu Y, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, Negassa A, Montgomery LL, Wiechmann LS, Alpaugh RK, Huang M, et al. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Research and Treatment. 146: 145-52. PMID 24903226 DOI: 10.1007/S10549-014-3008-5  0.424
2014 Tu Y, Hershman DL, Pellegrino CM, Andreopoulou E, Makower D, Fineberg S, Bhalla KN, Kalinsky K, Fehn K, Huang M, Alpaugh RK, Sparano JA. Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Journal of Clinical Oncology. 32: 598-598. DOI: 10.1200/Jco.2014.32.15_Suppl.598  0.368
2008 Tu Y, Roberts L, Shetty K, Schneider SS. Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines. Journal of Medicinal Food. 11: 413-23. PMID 18800886 DOI: 10.1089/Jmf.2007.0736  0.466
2005 Tu Y, Jerry DJ, Pazik B, Smith Schneider S. Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland. Molecular Cancer Research : McR. 3: 435-42. PMID 16123139 DOI: 10.1158/1541-7786.Mcr-05-0038  0.316
Show low-probability matches.